Company News 

Seven Days: 19 June 2020

Seven Days: 19 June 2020

Treatment hope

“Ground-breaking development”

Dexamethasone – a low-dose, inexpensive steroid treatment – “is the first drug to be shown to improve survival in Covid-19”, according to one of the chief investigators for the UK trial. Data from the trial suggests that dexamethasone reduced deaths by one-third in ventilated patients and by one-fifth in other patients receiving oxygen only. There was no benefit in patients who did not require respiratory support. The UK government’s chief scientific adviser, Sir Patrick Vallance, called this “tremendous news” and a “ground-breaking development”.

To continue reading, subscribe today

and enjoy unlimited access to the following:

  • Tips of the Week
  • Funds coverage
  • Weekly features on big investment themes
  • Trading ideas
  • Comprehensive companies coverage
  • Economic analysis
Subscribe to Investors Chronicle

Related topics

Subscribe today

Full access for just £3.37 a week:

• Tips and recommendations - to beat the market 
• Portfolio clinic & Mr Bearbull - build a well-planned portfolio 
• Expert tools - track and manage investments effortlessly
• Plus free delivery to your home or office

Subscribe Now